Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in Allergic Conjunctivitis

This study has been completed.
Sponsor:
Information provided by:
Vistakon Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00432757
First received: February 4, 2007
Last updated: April 8, 2009
Last verified: April 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2007
  Estimated Primary Completion Date: No date given